Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tracking gene expression in primary immunodeficiencies.

Haiying Qin1, Masafumi Yamada, Lan Tian

  • 1National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Current Opinion in Allergy and Clinical Immunology
|November 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma.

Journal for immunotherapy of cancer·2026
Same author

PG-MCTFormer: A Prior-Guided Multi-Scale Convolutional Transformer for Interpretable Motor Imagery EEG Classification.

Biomimetics (Basel, Switzerland)·2026
Same author

Tailoring Surface Chemistry for Robust and Ambient-Stable Sodium Layered Oxide Cathodes.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Polymorphic CGG repeats in gene regulation and disease.

American journal of human genetics·2026
Same author

Discovery and Evaluation of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives as P-gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells.

ChemMedChem·2026
Same author

Influence of raw material on the physical-chemical profile of cachaça: effects of variety and sugarcane cutting conditions.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Microarray technology accelerates the discovery of gene expression disturbances in primary immunodeficiency diseases. This powerful tool aids in molecular diagnosis and identifies potential drug targets for these conditions.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Recent decades of molecular genetics research have elucidated primary immunodeficiency disease mechanisms.
  • Microarray technology allows simultaneous surveying of thousands of gene expressions.

Purpose of the Study:

  • Review commonly used microarray arrays and their applications in primary immunodeficiency disease studies.
  • Highlight the role of microarrays in accelerating gene discovery and aiding molecular diagnostics for immunodeficiencies.

Main Methods:

  • Focus on microarray technology for surveying gene expression.
  • Analysis of differential gene expression in patients versus normal controls.

Main Results:

  • Microarray analysis has been applied to various immunodeficiency diseases, including those with known and unknown genetic causes.

Related Experiment Videos

  • This technology provides molecular phenotypes, offering insights into cellular responses under specific conditions.
  • Comparative studies reveal molecular-level understanding of immunodeficiencies.

    • Conclusions:

    • Microarray technology enables simultaneous tracking of thousands of genes, facilitating disease diagnosis and supplementing clinical phenotypes.
    • It serves as a powerful survey tool for detecting disturbed gene expression, guiding disease gene discovery.
    • Microarray findings offer potential targets for novel drug development in immunodeficiency research.